People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Health Care, Other, Healthtech, Retailing, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Potrero Medical, Inc. | — | Biotechnology | Series B | $76.2M | $9.9M | 2014 |
| Channel Medsystems, Inc. | — | Other Health Care | Series B | $54.7M | $35.8M | 2013 |
| Velomedix, Inc. | — | Biotechnology | Series A | $27.3M | $335.9M | 2009 |
| Centese, Inc. | — | Other Health Care | Series B | $15.6M | $2.7M | 2025 |
| Emkinetics Inc | — | Other | Series A | $14.8M | $3.8M | 2009 |
| Gravitas Medical, Inc. | — | Biotechnology | Series A | $4.7M | $113.7M | 2021 |
| Bone Health Technologies, Inc. | — | Biotechnology | Seed | $3.7M | $29.8M | 2019 |
| Piccolo Medical, Inc. | — | Healthtech | Seed | $3.3M | $27.7M | 2018 |
| Gold Capital, LLC | — | Retailing | Seed | $3.0M | $12.0M | 2012 |
| Respirix, Inc. | — | Other Health Care | Seed | $1.3M | $32.2M | 2018 |
| JustAir, Inc. | — | Other Technology | Seed | $1.0M | $34.8M | 2020 |
Daniel Burnett at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Burnett on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alan Chesler | 4 | 5 |
| Carter Meyer | 3 | 14 |
| Evan Luxon | 2 | 3 |
| Dan Burnett | 2 | 2 |
| David Greenberg | 1 | 13 |
| Frederic H. Moll | 1 | 8 |
| Maurice Ferre | 1 | 5 |
| J. Casey McGlynn | 1 | 5 |
| Andrew Cleeland | 1 | 5 |
| John Dean | 1 | 5 |
| David Amerson | 1 | 5 |
| Andrew ` Offer | 1 | 5 |
| John Osborne | 1 | 5 |
| Andrew Farquharson | 1 | 4 |
| Anthony Natale | 1 | 4 |
| Christopher Dewey | 1 | 4 |
| Ken Ludlum | 1 | 3 |
| Richard Emmitt | 1 | 3 |
| Sam Goldberger | 1 | 3 |
| Casey McGlynn | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.